TMEFF2 and SARDH cooperate to modulate one-carbon metabolism and invasion of prostate cancer cells

Prostate

Volumn 73, Issue 14, 2013, Pages 1561-1575

  Green, Thomas ^a   Chen, Xiaofei ^a   Ryan, Stephen ^a,c   Asch, Adam S ^a,b   Ruiz Echevarría, Maria J ^a,b  

^a EAST CAROLINA UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c MAINE MEDICAL CENTER   (United States)

Author keywords

cellular invasion; metabolism; prostate cancer; tissue culture

Indexed keywords

ACTIN; CARBON; FOLIC ACID; MEMBRANE PROTEIN; METHOTREXATE; SARCOSINE; SARCOSINE DEHYDROGENASE; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; TRANSMEMBRANE PROTEIN WITH EPIDERMAL GROWTH FACTOR AND TWO FOLLISTATIN MOTIF; TUBULIN; UNCLASSIFIED DRUG;

ARTICLE; CARBON METABOLISM; CELL COUNT; CELL FRACTIONATION; CELL INVASION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; MASS SPECTROMETRY; ONE CARBON METABOLISM; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR INVASION; WESTERN BLOTTING;

CELLULAR INVASION; METABOLISM; PROSTATE CANCER; TISSUE CULTURE;

ANTIMETABOLITES, ANTINEOPLASTIC; CARBON; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; MALE; MEMBRANE PROTEINS; METHOTREXATE; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PROSTATE; PROSTATIC NEOPLASMS; SARCOSINE; SARCOSINE DEHYDROGENASE; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 84883192086     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22706     Document Type: Article

References (50)

1. Hanahan D, Weinberg RA,. Hallmarks of cancer: The next generation. Cell 2011; 144: 646-674.
2. Dang CV,. Links between metabolism and cancer. Genes Dev 2012; 26: 877-890.
3. Fox JT, Stover PJ,. Folate-mediated one-carbon metabolism. Vitam Horm 2008; 79: 1-44.
4. Cebrian A, Pharoah PD, Ahmed S, Ropero S, Fraga MF, Smith PL, Conroy D, Luben R, Perkins B, Easton DF, Dunning AM, Esteller M, Ponder BA,. Genetic variants in epigenetic genes and breast cancer risk. Carcinogenesis 2006; 27: 1661-1669.
5. Hubner RA, Muir KR, Liu JF, Sellick GS, Logan RF, Grainge M, Armitage N, Chau I, Houlston RS,. Folate metabolism polymorphisms influence risk of colorectal adenoma recurrence. Cancer Epidemiol Biomarkers Prev 2006; 15: 1607-1613.
6. Kelemen LE, Sellers TA, Schildkraut JM, Cunningham JM, Vierkant RA, Pankratz VS, Fredericksen ZS, Gadre MK, Rider DN, Liebow M, Goode EL,. Genetic variation in the one-carbon transfer pathway and ovarian cancer risk. Cancer Res 2008; 68: 2498-2506.
7. Lim U, Wang SS, Hartge P, Cozen W, Kelemen LE, Chanock S, Davis S, Blair A, Schenk M, Rothman N, Lan Q,. Gene-nutrient interactions among determinants of folate and one-carbon metabolism on the risk of non-Hodgkin lymphoma: NCI-SEER case-control study. Blood 2007; 109: 3050-3059.
8. Shen H, Wang L, Spitz MR, Hong WK, Mao L, Wei Q,. A novel polymorphism in human cytosine DNA-methyltransferase-3B promoter is associated with an increased risk of lung cancer. Cancer Res 2002; 62: 4992-4995.
9. Zhang Z, Shi Q, Liu Z, Sturgis EM, Spitz MR, Wei Q,. Polymorphisms of methionine synthase and methionine synthase reductase and risk of squamous cell carcinoma of the head and neck: A case-control analysis. Cancer Epidemiol Biomarkers Prev 2005; 14: 1188-1193.
10. Bedford MT, Clarke SG,. Protein arginine methylation in mammals: Who, what, and why. Mol Cell 2009; 33: 1-13.
11. Limm K, Ott C, Wallner S, Mueller DW, Oefner P, Hellerbrand C, Bosserhoff A,. Deregulation of protein methylation in melanoma. Eur J Cancer 2013; 49: 1305-1313.
12. Watanabe H, Soejima K, Yasuda H, Kawada I, Nakachi I, Yoda S, Naoki K, Ishizaka A,. Deregulation of histone lysine methyltransferases contributes to oncogenic transformation of human bronchoepithelial cells. Cancer Cell Int 2008; 8: 15.
13. Yang Y, Bedford MT,. Protein arginine methyltransferases and cancer. Nat Rev Cancer 2013; 13: 37-50.
14. Yu Z, Chen T, Hebert J, Li E, Richard S,. A mouse PRMT1 null allele defines an essential role for arginine methylation in genome maintenance and cell proliferation. Mol Cell Biol 2009; 29: 2982-2996.
15. Herman JG, Baylin SB,. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003; 349: 2042-2054.
16. Jones PA, Baylin SB,. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002; 3: 415-428.
17. Momparler RL, Cancer epigenetics,. Oncogene 2003; 22: 6479-6483.
18. Qiu P, Zhang L,. Identification of markers associated with global changes in DNA methylation regulation in cancers. BMC Bioinformatics 2012; 13 (Suppl 13): S7.
19. Deneberg S, Grovdal M, Karimi M, Jansson M, Nahi H, Corbacioglu A, Gaidzik V, Dohner K, Paul C, Ekstrom TJ, Hellstrom-Lindberg E, Lehmann S,. Gene-specific and global methylation patterns predict outcome in patients with acute myeloid leukemia. Leukemia 2010; 24: 932-941.
20. Feinberg AP, Vogelstein B,. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 1983; 301: 89-92.
21. Feinberg AP, Ohlsson R, Henikoff S,. The epigenetic progenitor origin of human cancer. Nat Rev Genet 2006; 7: 21-33.
22. Zhang WC, Shyh-Chang N, Yang H, Rai A, Umashankar S, Ma S, Soh BS, Sun LL, Tai BC, Nga ME, Bhakoo KK, Jayapal SR, Nichane M, Yu Q, Ahmed DA, Tan C, Sing WP, Tam J, Thirugananam A, Noghabi MS, Pang YH, Ang HS, Mitchell W, Robson P, Kaldis P, Soo RA, Swarup S, Lim EH, Lim B,. Glycine decarboxylase activity drives non-small cell lung cancer tumor-initiating cells and tumorigenesis. Cell 2012; 148: 259-272.
23. Jain M, Nilsson R, Sharma S, Madhusudhan N, Kitami T, Souza AL, Kafri R, Kirschner MW, Clish CB, Mootha VK,. Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation. Science 2012; 336: 1040-1044.
24. Locasale JW, Grassian AR, Melman T, Lyssiotis CA, Mattaini KR, Bass AJ, Heffron G, Metallo CM, Muranen T, Sharfi H, Sasaki AT, Anastasiou D, Mullarky E, Vokes NI, Sasaki M, Beroukhim R, Stephanopoulos G, Ligon AH, Meyerson M, Richardson AL, Chin L, Wagner G, Asara JM, Brugge JS, Cantley LC, Vander Heiden MG,. Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nat Genet 2011; 43: 869-874.
25. Possemato R, Marks KM, Shaul YD, Pacold ME, Kim D, Birsoy K, Sethumadhavan S, Woo HK, Jang HG, Jha AK, Chen WW, Barrett FG, Stransky N, Tsun ZY, Cowley GS, Barretina J, Kalaany NY, Hsu PP, Ottina K, Chan AM, Yuan B, Garraway LA, Root DE, Mino-Kenudson M, Brachtel EF, Driggers EM, Sabatini DM,. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature 2011; 476: 346-350.
26. Putluri N, Shojaie A, Vasu VT, Nalluri S, Vareed SK, Putluri V, Vivekanandan-Giri A, Byun J, Pennathur S, Sana TR, Fischer SM, Palapattu GS, Creighton CJ, Michailidis G, Sreekumar A,. Metabolomic profiling reveals a role for androgen in activating amino acid metabolism and methylation in prostate cancer cells. PLoS ONE 2011; 6: e21417.
27. Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y, Nyati MK, Ahsan A, Kalyana-Sundaram S, Han B, Cao X, Byun J, Omenn GS, Ghosh D, Pennathur S, Alexander DC, Berger A, Shuster JR, Wei JT, Varambally S, Beecher C, Chinnaiyan AM,. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 2009; 457: 910-914.
28. Heanue TA, Pachnis V,. Expression profiling the developing mammalian enteric nervous system identifies marker and candidate Hirschsprung disease genes. Proc Natl Acad Sci USA 2006; 103: 6919-6924.
29. Uchida T, Wada K, Akamatsu T, Yonezawa M, Noguchi H, Mizoguchi A, Kasuga M, Sakamoto C,. A novel epidermal growth factor-like molecule containing two follistatin modules stimulates tyrosine phosphorylation of erbB-4 in MKN28 gastric cancer cells. Biochem Biophys Res Commun 1999; 266: 593-602.
30. Afar DE, Bhaskar V, Ibsen E, Breinberg D, Henshall SM, Kench JG, Drobnjak M, Powers R, Wong M, Evangelista F, O'Hara C, Powers D, DuBridge RB, Caras I, Winter R, Anderson T, Solvason N, Stricker PD, Cordon-Cardo C, Scher HI, Grygiel JJ, Sutherland RL, Murray R, Ramakrishnan V, Law DA,. Preclinical validation of anti-TMEFF2-auristatin E-conjugated antibodies in the treatment of prostate cancer. Mol Cancer Ther 2004; 3: 921-932.
31. Gery S, Koeffler HP,. Repression of the TMEFF2 promoter by c-Myc. J Mol Biol 2003; 328: 977-983.
32. Glynne-Jones E, Harper ME, Seery LT, James R, Anglin I, Morgan HE, Taylor KM, Gee JM, Nicholson RI,. TENB2, a proteoglycan identified in prostate cancer that is associated with disease progression and androgen independence. Int J Cancer 2001; 94: 178-184.
33. Mohler JL, Morris TL, Ford OH III, Alvey RF, Sakamoto C, Gregory CW,. Identification of differentially expressed genes associated with androgen-independent growth of prostate cancer. Prostate 2002; 51: 247-255.
34. Chen X, Overcash R, Green T, Hoffman D, Asch AS, Ruiz-Echevarría MJ,. The tumor suppressor activity of the transmembrane protein with epidermal growth factor and two follistatin motifs 2 (TMEFF2) correlates with its ability to modulate sarcosine levels. J Biol Chem 2011; 286: 16091-16100.
35. Pappin DJ, Hojrup P, Bleasby AJ,. Rapid identification of proteins by peptide-mass fingerprinting. Curr Biol 1993; 3: 327-332.
36. Elahi A, Zhang L, Yeatman TJ, Gery S, Sebti S, Shibata D,. HPP1-mediated tumor suppression requires activation of STAT1 pathways. Int J Cancer 2008; 122: 1567-1572.
37. Gery S, Sawyers CL, Agus DB, Said JW, Koeffler HP,. TMEFF2 is an androgen-regulated gene exhibiting antiproliferative effects in prostate cancer cells. Oncogene 2002; 21: 4739-4746.
38. Khan AP, Rajendiran TM, Ateeq B, Asangani IA, Athanikar JN, Yocum AK, Mehra R, Siddiqui J, Palapattu G, Wei JT, Michailidis G, Sreekumar A, Chinnaiyan AM,. The role of sarcosine metabolism in prostate cancer progression. Neoplasia 2013; 15: 491-501.
39. Cao DL, Ye DW, Zhu Y, Zhang HL, Wang YX, Yao XD,. Efforts to resolve the contradictions in early diagnosis of prostate cancer: A comparison of different algorithms of sarcosine in urine. Prostate Cancer Prostatic Dis 2011; 14: 166-172.
40. Luka Z, Mudd SH, Wagner C,. Glycine N-methyltransferase and regulation of S-adenosylmethionine levels. J Biol Chem 2009; 284: 22507-22511.
41. Petersen LF, Brockton NT, Bakkar A, Liu S, Wen J, Weljie AM, Bismar TA,. Elevated physiological levels of folic acid can increase in vitro growth and invasiveness of prostate cancer cells. BJU Int 2011; 109: 788-795.
42. Choi SW, Mason JB,. Folate and carcinogenesis: An integrated scheme. J Nutr 2000; 130: 129-132.
43. Bester AC, Roniger M, Oren YS, Im MM, Sarni D, Chaoat M, Bensimon A, Zamir G, Shewach DS, Kerem B,. Nucleotide deficiency promotes genomic instability in early stages of cancer development. Cell 2011; 145: 435-446.
44. Baldwin RM, Morettin A, Paris G, Goulet I, Côté J,. Alternatively spliced protein arginine methyltransferase 1 isoform PRMT1v2 promotes the survival and invasiveness of breast cancer cells. Cell Cycle 2012; 11: 4597-4612.
45. Zhuang J, Jones A, Lee SH, Ng E, Fiegl H, Zikan M, Cibula D, Sargent A, Salvesen HB, Jacobs IJ, Kitchener HC, Teschendorff AE, Widschwendter M,. The dynamics and prognostic potential of DNA methylation changes at stem cell gene loci in women's cancer. PLoS Genet 2012; 8: e1002517.
46. Overcash R, Chappell V, Green T, Geyer C, Asch A, Ruiz-Echevarría M,. Androgen signaling promotes translation of TMEFF2 in prostate cancer cells via phosphorylation of the alpha subunit of the translation initiation factor 2 (eIF2α). PLoS ONE 2013; 8: e55257.
47. Kinoshita H, Shi Y, Sandefur C, Meisner LF, Chang C, Choon A, Reznikoff CR, Bova GS, Friedl A, Jarrard DF,. Methylation of the androgen receptor minimal promoter silences transcription in human prostate cancer. Cancer Res 2000; 60: 3623-3630.
48. Gaughan L, Stockley J, Wang N, McCracken SRC, Treumann A, Armstrong K, Shaheen F, Watt K, McEwan IJ, Wang C, Pestell RG, Robson CN,. Regulation of the androgen receptor by SET9-mediated methylation. Nucleic Acids Res 2011; 39: 1266-1279.
49. Ko S, Ahn J, Song CS, Kim S, Knapczyk-Stwora K, Chatterjee B,. Lysine methylation and functional modulation of androgen receptor by Set9 methyltransferase. Mol Endocrinol 2011; 25: 433-444.
50. Lin K, Taylor JR Jr, Wu TD, Gutierrez J, Elliott JM, Vernes JM, Koeppen H, Phillips HS, de Sauvage FJ, Meng YG,. TMEFF2 is a PDGF-AA binding protein with methylation-associated gene silencing in multiple cancer types including glioma. PLoS ONE 2011; 6: e18608.